The FDA announced on March 29, 2021, that Greiner Bio-One North America, Inc. is recalling VACUETTE Blood Collection tubes due to insufficient draw volume that could produce erroneous coagulation test results. The agency has classified this Class II recall as terminated.
How to tell if you have it
- Brand: Greiner Bio-One
- Product: VACUETTE Blood Collection tube 9NC Coagulation sodium citrate 3.2% 13x75 blue cap-white ring, sandwich tube
- Item Number: 454322; Lot # A21023B5; UDI: (Case) 39120017574485 and (Rack) 29120017574488; Expiration Date: 02/06/2022
- Item Number: 454332; Lot # A210338Q; UDI: (Case) 39120017574607 and (Rack) 29120017574600; Expiration Date: 03/01/2022
- Item Number: 454334; Lot # A210233V; UDI: (Case) 39120017574539 and (Rack) 29120017574532; Expiration Date: 02/01/2022
- Item Number: 454334; Lot # A21023XW; UDI: (Case) 39120017574539 and (Rack) 29120017574532; Expiration Date: 02/13/2022
- Units affected: 1,049,700
The hazard
According to the FDA, the VACUETTE Blood Collection tubes may show insufficient draw volume, which could produce erroneous results for prothrombin time, activated partial thromboplastin time, and fibrinogen assays.
Context
GovInfoNow's records show Greiner Bio-One North America, Inc. has 11 other recalls on record since 2019-11-25. Other recent recalls of similar products include Vacuette 8ml CAT Serum Separator Clot Activator Tubes May Cause Incorrect Test Results (2025-08-19), Greiner Bio-One VACUETTE 2ml Coagulation Tubes: Incorrect Fill Level Label May Cause Repeat Collections (2025-08-08), and Greiner Bio-One VACUETTE Tube Recall: Clotting Issues May Delay Treatment (2024-05-14).